# QuartumSE Strategic Review & Next Steps
**Date**: 2025-10-30
**Reviewer**: Claude (AI Assistant)
**Context**: In-depth project review at Phase 1 midpoint
**Target Audience**: Project leadership and technical leads

---

## Executive Summary

**TL;DR**: QuartumSE has solid technical foundations and clear strategic vision, but Phase 1 execution is **significantly behind schedule**. CI/CD infrastructure is now robust, but **actual quantum experiments and data collection are minimal**. The project needs to **shift from infrastructure work to experimental execution** immediately to meet Phase 1 exit criteria by Nov 2025.

**Current Status**: ⚠️ **Phase 1 at risk** - Infrastructure ✅ Complete, Experiments ❌ Behind

### Key Findings

| Area | Status | Risk Level |
|------|--------|------------|
| **Infrastructure & CI/CD** | ✅ Robust | 🟢 Low |
| **Documentation** | ✅ Comprehensive | 🟢 Low |
| **Code Quality** | ⚠️ 23% coverage | 🟡 Medium |
| **Phase 1 Experiments** | ❌ Incomplete | 🔴 **High** |
| **Hardware Validation** | ❌ Not started | 🔴 **Critical** |
| **Timeline** | ⚠️ 1 month to deadline | 🔴 **Critical** |

---

## Part 1: Current State Assessment

### 1.1 What's Working Well ✅

#### Infrastructure Excellence
- **CI/CD Pipeline**: Expanded from 1→9 jobs (6 test configs, 3 integration platforms)
- **Documentation**: 27 markdown files, professional MkDocs site at quartumse.com
- **Custom Domain**: CNAME properly configured and persisting across deployments
- **Sphinx API Docs**: 0 warnings after fixing 44→17→10→0 regression
- **Lessons Learned**: Comprehensive documentation of debugging processes
- **Git Workflow**: 195 commits this month, active development

**Verdict**: Infrastructure is **production-ready** for a Phase 1 R&D project.

#### Strategic Clarity
- **Vision**: Clear positioning as "vendor-neutral quantum observability layer"
- **Roadmap**: Detailed 5-phase plan (2025-2026) with explicit gates
- **Metrics**: Well-defined success criteria (SSR, RMSE@$, CI coverage)
- **Competitive Analysis**: Strong differentiation from Mitiq, Q-CTRL, vendor SDKs
- **IP Strategy**: Patent themes identified, publication plan in place

**Verdict**: Strategic direction is **sound and defensible**.

### 1.2 Critical Gaps ❌

#### Experimental Execution (CRITICAL)

**Phase 1 Task Checklist Status** (from phase1_task_checklist.md):

| Task Category | Checked | Unchecked | Completion |
|---------------|---------|-----------|------------|
| Infrastructure | 4/4 | 0 | **100%** ✅ |
| S-T01/T02 Extended GHZ | 0/5 | 5 | **0%** ❌ |
| S-BELL Parallel Bell | 0/4 | 4 | **0%** ❌ |
| S-CLIFF Random Clifford | 0/4 | 4 | **0%** ❌ |
| S-ISING Ising Chain | 0/4 | 4 | **0%** ❌ |
| S-CHEM H₂ Energy | 0/4 | 4 | **0%** ❌ |
| Cross-experiment reporting | 0/2 | 2 | **0%** ❌ |
| Hardware validation | 0/3 | 3 | **0%** ❌ |
| C/O/B/M starters | 0/2 | 2 | **0%** ❌ |
| **TOTAL** | **4/36** | **32** | **11%** |

**Reality check**:
- ✅ **1 experiment** has results: S-T01 smoke test (Oct 22, 2025) on ibm_torino
- ❌ **0 validation datasets** in validation_data/ directory
- ❌ **0 experiment results** stored in experiments/shadows/*/results/
- ❌ **32 unchecked tasks** with 1 month until Phase 1 deadline (Nov 2025)

**Verdict**: **CRITICAL BLOCKER** - The project has excellent infrastructure but minimal experimental data.

#### Code Coverage (MEDIUM PRIORITY)

```
Total Coverage: 23%
Lines: 2,455 valid, 562 covered, 1,893 uncovered
```

**Most Undercovered Modules**:
- `utils/metrics.py`: 21% (404 lines, 319 uncovered) - Analysis utilities
- `utils/runtime_monitor.py`: 21% (214 lines, 169 uncovered) - IBM Runtime monitoring
- `reporting/manifest_io.py`: 15% (91 lines, 77 uncovered) - Manifest loading/saving
- `shadows/v0_baseline.py`: 16% (80 lines, 67 uncovered) - Core algorithm!
- `shadows/v1_noise_aware.py`: 16% (73 lines, 61 uncovered) - Core algorithm!

**Why this matters**:
- Core shadow algorithms (v0/v1) are barely tested (16% coverage)
- Analysis utilities are untested (21% coverage)
- Risk of bugs in production experiments

**Verdict**: Code quality is **adequate for R&D** but needs improvement before Phase 3 (public beta).

### 1.3 Resource Allocation Analysis

**October 2025 Activity Breakdown** (estimated from commits):

| Activity | Commits | % Time | Value |
|----------|---------|--------|-------|
| CI/CD fixes | ~40 | 20% | Infrastructure |
| Documentation | ~50 | 26% | Quality |
| Sphinx debugging | ~25 | 13% | Infrastructure |
| Test expansion | ~30 | 15% | Quality |
| **Experiments** | ~**20** | **10%** | **Core Mission** ❗ |
| Other (deps, config) | ~30 | 16% | Maintenance |

**Problem**: Only ~10% of effort went to actual experiments (the core Phase 1 deliverable).

**Opportunity cost**:
- 40 commits on CI/CD = ~2 weeks of development time
- Could have completed 3-4 experiment campaigns
- Infrastructure is necessary, but **over-invested relative to experimental progress**

---

## Part 2: Phase 1 Exit Criteria Analysis

### 2.1 Roadmap Phase 1 Goals (from roadmap.md)

**Exit Criteria**:
1. ✅ End-to-end run from notebook → manifest → report on Aer
2. ⚠️ + at least one IBM free-tier backend (partial: 1 smoke test only)
3. ❌ SSR ≥ 1.2× on Shadows-Core (sim) and ≥ 1.1× (IBM)
4. ❌ CI coverage ≥ 80% (current: 23%)
5. ❌ Zero critical issues, reproducible seeds & manifests
6. ❌ Patent themes shortlist (top-3) + experiment data to support novelty

**Status**: **1/6 complete** (17%)

### 2.2 Experiment Deliverables Gap

**Required (from roadmap.md)**:
- S-T01: GHZ(3-5), ⟨Zᵢ⟩, ⟨ZᵢZⱼ⟩, purity, SSR ≥ 1.2 (sim), ≥ 1.1 (IBM)
- S-T02: Calibrate inverse channel, variance reduction comparison
- C-T01: H₂@STO-3G VQE, energy error ≤ 50 mHa (sim), ≤ 80 mHa (IBM)
- O-T01: QAOA on 5-node ring, shot-frugal optimizer comparison
- B-T01: 1-3 qubit RB, XEB, log to manifest
- M-T01: GHZ(3-4) phase sensing, CI coverage ≥ 0.8

**Actual**:
- ✅ S-T01 smoke test (1 run, Oct 22, ibm_torino, SSR ≥ 1.2)
- ❌ S-T02, C-T01, O-T01, B-T01, M-T01: **Not started**

**Data Gap**:
- Need: ≥10 hardware trials per experiment for statistical validation
- Have: 1 smoke test
- **Gap**: ~55 more hardware runs needed (6 experiments × 10 trials - 1 done)

### 2.3 Timeline Pressure

**Days remaining**: ~31 days (Oct 30 → Nov 30, 2025)

**Required work**:
- 5 experiments × (design + implement + 10 hardware runs + analysis) = ~125 person-hours
- Patent theme shortlist + supporting data documentation = ~20 hours
- Code coverage improvement (23% → 80%) = ~80 hours
- **Total**: ~225 person-hours in 31 days = **7.3 hours/day** (aggressive but achievable)

**Risk**: If current pace continues (10% on experiments), Phase 1 will **slip by 2-3 months**.

---

## Part 3: Strategic Priorities & Recommendations

### 3.1 Immediate Actions (Next 7 Days) 🚨

#### Priority 1: Shift to Experimental Execution

**STOP**:
- ❌ Further CI/CD enhancements (already production-ready)
- ❌ Documentation polish (already comprehensive)
- ❌ Infrastructure work (defer to Phase 2)

**START**:
- ✅ **Daily hardware runs**: Schedule IBM Quantum jobs systematically
- ✅ **Experiment execution sprints**: Focus blocks of 3-4 hours on single experiments
- ✅ **Results-first mindset**: Get data, analyze later if needed

#### Priority 2: Execute S-T01/S-T02 Extended Validation

**Actionable Steps**:
1. **Day 1-2**: Run S-T01 extended (GHZ 4-5 qubits, 10 trials on ibm_torino or ibm_brisbane)
   - Use existing `experiments/shadows/S_T01_ghz_baseline.py`
   - Add `--trials=10` flag and batch execution
   - Store results in `validation_data/s_t01/`

2. **Day 3-4**: Implement S-T02 noise-aware comparison
   - Add MEM calibration to S-T01 script
   - Run with/without MEM (10 trials each)
   - Document variance reduction

3. **Day 5-7**: Analysis and reporting
   - Compute SSR, CI coverage, MAE across all trials
   - Generate manifests and HTML reports
   - Write discussion notes for patent themes

**Deliverables**:
- 20+ hardware runs with manifests
- SSR validation data for Phase 1 gate
- First material for patent provisional draft

#### Priority 3: Skeleton Implementations for C/O/B/M

**Don't aim for perfection - aim for data**:

- **C-T01 (Chemistry)**:
  - Use existing qiskit.opflow VQE example
  - Run H₂ with 2-3 parameter settings
  - Compare shadow vs grouped readout
  - **Target**: 3 runs × 2 methods = 6 data points

- **O-T01 (Optimization)**:
  - QAOA p=1 on 5-node MAX-CUT
  - Fixed parameters, just compare shot efficiency
  - **Target**: 2 runs × 2 shot budgets = 4 data points

- **B-T01 (Benchmarking)**:
  - 1-2 qubit RB (use qiskit.ignis)
  - Log to manifest, compare to IBM calibration
  - **Target**: 2 RB sequences

- **M-T01 (Metrology)**:
  - GHZ(3) with Z-rotation parameter estimation
  - **Target**: 1 proof-of-concept run

**Time estimate**: 2 days per workstream = 8 days total

**Rationale**: Phase 1 needs **breadth** (all workstreams touched) more than **depth** (perfect implementations). Get first data drops to validate end-to-end workflow.

### 3.2 Medium-Term Actions (Next 2-3 Weeks)

#### Iterative Hardware Campaigns

**Week 1** (Nov 1-7):
- S-T01/S-T02 extended validation (20 runs)
- C-T01 chemistry starter (6 runs)
- Document results continuously

**Week 2** (Nov 8-14):
- O-T01 optimization starter (4 runs)
- B-T01 benchmarking starter (2 runs)
- M-T01 metrology starter (1 run)

**Week 3** (Nov 15-21):
- Repeat high-value experiments for statistical power
- Analysis sprint: compute all Phase 1 metrics
- Patent theme drafting with experimental evidence

**Week 4** (Nov 22-30):
- Cross-experiment reporting
- Phase 1 gate review preparation
- Phase 2 planning

#### Code Quality Improvements

**Defer large refactors**, but do:
1. Add integration tests for each new experiment (adds ~10% coverage each)
2. Test analysis utilities as experiments generate data
3. Focus on **experiment reproducibility tests** (most valuable for Phase 1)

**Goal**: Reach 40-50% coverage (realistic for R&D phase) rather than 80% (defer to Phase 3).

### 3.3 Risks & Mitigation

| Risk | Probability | Impact | Mitigation |
|------|-------------|--------|------------|
| **IBM Runtime quota exhaustion** | High | Critical | Use `quartumse runtime-status` weekly; batch jobs; prioritize S-T01/S-T02 |
| **Experiments fail (low SSR)** | Medium | High | Accept partial results; document learnings; adjust Phase 2 |
| **Phase 1 deadline missed** | High | Medium | Negotiate 1-month extension; reframe as "Phase 1.5" |
| **Hardware access issues** | Medium | High | Pre-book time windows; have Aer backup for dev/test |
| **Burnout from pressure** | Medium | Critical | Work sustainably; 7hrs/day not 12hrs/day |

---

## Part 4: Technical Debt & Code Quality

### 4.1 Current Technical Debt

**High Priority** (address in Phase 2):
1. **Shadow algorithms barely tested** (16% coverage)
   - Core v0/v1 implementations need unit tests
   - Edge cases (empty observables, invalid configs) untested

2. **Reporting pipeline fragile**
   - 15-20% coverage on manifest I/O
   - Error handling for corrupted manifests missing

3. **No integration tests for hardware**
   - All integration tests use Aer
   - Real IBM backend behavior untested in CI

**Medium Priority** (address in Phase 3):
1. **Type coverage incomplete**
   - Many functions lack type annotations
   - Mypy likely missing issues

2. **Experiment reproducibility**
   - Seeds not fully deterministic
   - Manifest replay not tested end-to-end

3. **Error messages not user-friendly**
   - Stack traces instead of actionable guidance
   - No troubleshooting docs for common issues

**Low Priority** (defer to Phase 4+):
1. **Performance optimization**
   - No profiling done
   - Shadow estimation could be vectorized

2. **Logging consistency**
   - Mix of print(), logging, rich.console
   - No structured logging

### 4.2 Code Quality Quick Wins

**If time permits** (don't prioritize over experiments):
1. Add docstring examples to top 5 public APIs
2. Write tests for `utils/args.py` (already used, should be solid)
3. Add error handling to manifest loading
4. Create troubleshooting guide for common setup issues

---

## Part 5: Resource & Workload Planning

### 5.1 Realistic Capacity Assessment

**Assumptions**:
- 1 developer (you + Claude assist)
- 4-6 effective hours/day (sustainable pace)
- 31 days remaining in Phase 1

**Available capacity**: 124-186 hours

**Required work** (revised estimates):
| Task | Hours | Priority |
|------|-------|----------|
| S-T01/T02 extended validation | 40 | P0 |
| C/O/B/M starter experiments | 50 | P0 |
| Analysis & reporting | 30 | P0 |
| Patent theme drafting | 15 | P1 |
| Code coverage to 40% | 30 | P2 |
| Phase 1 gate review prep | 10 | P1 |
| **P0+P1 Total** | **145** | Fits in capacity ✅ |

**Verdict**: Phase 1 exit criteria **achievable** if focus shifts to experiments immediately.

### 5.2 Recommended Work Allocation

**Going forward** (next 31 days):
- **70%** on experiments (hardware runs, analysis, reporting)
- **15%** on documentation (results write-up, patent themes)
- **10%** on code quality (tests for new code only)
- **5%** on infrastructure (bug fixes only, no enhancements)

Compare to **current allocation**:
- 10% experiments → **70%** experiments (7× increase) ✅

---

## Part 6: Strategic Positioning & Competitive Analysis

### 6.1 Market Positioning Strengths

**Differentiation is clear**:
1. **Vendor-neutrality**: Real advantage as IBM/AWS/IonQ compete
2. **Provenance**: Unique offering in quantum space
3. **Cost-for-accuracy metrics**: Novel framing (RMSE@$)
4. **Multi-observable reuse**: Classical shadows USP

**Patent themes** (from project_bible.md):
1. Variance-Aware Adaptive Classical Shadows (VACS) ✅ Strong
2. Shadow-VQE readout integration ✅ Strong
3. Shadow-Benchmarking workflow ✅ Moderate

**Recommendation**: Focus on **VACS** for first provisional - most defensible IP.

### 6.2 Competitive Threats

| Competitor | Threat Level | Mitigation |
|------------|--------------|------------|
| **Mitiq** (Unitary Fund) | Medium | They do mitigation, not shadows; different scope |
| **Q-CTRL Fire Opal** | Low | Commercial, expensive; we're open + auditable |
| **IBM Estimator Primitive** | High | If IBM adds shadows to Qiskit, we lose USP |
| **Academic preprints** | Medium | Publish fast; file patents before arXiv |

**Urgency for IP protection**: **HIGH** - Shadows are hot research area, file provisionals in Phase 2.

### 6.3 Publication Strategy

**Target venues** (from roadmap.md):
- PRX Quantum (high impact)
- npj Quantum Information (fast turnaround)
- Quantum journal (open access)

**Timing**:
- Phase 2 (Dec 2025): arXiv preprints
- Phase 3 (Q1 2026): journal submissions

**Critical**: Need **strong experimental data** from Phase 1 to support papers.

---

## Part 7: Phase 2 Planning Considerations

### 7.1 Phase 2 Objectives (from roadmap.md)

**Focus**: Hardware-first iteration & patent drafts (Nov-Dec 2025)

**Key deliverables**:
- Shadows v2 (Fermionic) for 2-RDM
- Shadows v3 (Adaptive/Derandomized)
- MEM + RC + ZNE combinations
- IBM hardware campaign #1 dataset
- Provisional patent draft(s)
- Two arXiv preprints

**Exit criteria**:
- SSR ≥ 1.3× on IBM
- Provisional patent(s) filed
- arXiv preprints ready

### 7.2 Recommended Phase 2 Adjustments

**If Phase 1 extends to Dec 2025** (likely):
- Merge Phase 1/2 into "Phase 1 Extended" (Nov-Dec)
- Defer Shadows v2/v3 to Phase 2 (Jan-Feb 2026)
- Keep patent/publication targets in Phase 2

**Rationale**: Better to complete Phase 1 properly than rush into Phase 2 with incomplete data.

### 7.3 Phase Boundary Flexibility

**Option A: Strict Gates** (current plan)
- Phase 1 → Phase 2 requires all 6 exit criteria
- Risk: May never advance if criteria too strict

**Option B: Flexible Gates** (recommended)
- Phase 1 → Phase 2 requires **core criteria only**:
  1. S-T01/S-T02 validation complete (SSR ≥ 1.1 on IBM)
  2. All workstreams touched (C/O/B/M starters exist)
  3. Manifest + reporting workflow proven
- Defer: Perfect CI coverage, zero issues, complete patent themes

**Recommendation**: Adopt **Option B** - focus on mission-critical experiments, accept some technical debt.

---

## Part 8: Next Actions (Prioritized)

### Immediate (This Week)

1. **📋 Create Experiment Execution Sprint Plan**
   - [ ] Schedule S-T01 extended runs (10 trials)
   - [ ] Book IBM Quantum time windows (check runtime-status)
   - [ ] Set up `validation_data/` directories for results
   - [ ] Create experiment execution checklist

2. **🔬 Start S-T01 Extended Validation**
   - [ ] Run GHZ(4) 10 times on IBM backend
   - [ ] Store manifests in `validation_data/s_t01/`
   - [ ] Analyze SSR, CI coverage, MAE
   - [ ] Write discussion notes

3. **📊 Baseline Current Phase 1 Status**
   - [ ] Update phase1_task_checklist.md with accurate checkboxes
   - [ ] Document what's actually complete vs planned
   - [ ] Estimate hours required for remaining tasks

### Short-Term (Next 2 Weeks)

4. **🧪 Execute C/O/B/M Starters**
   - [ ] C-T01: H₂ VQE (skeleton implementation)
   - [ ] O-T01: QAOA MAX-CUT (skeleton)
   - [ ] B-T01: RB sequences (skeleton)
   - [ ] M-T01: GHZ phase sensing (skeleton)

5. **📝 Patent Theme Drafting**
   - [ ] Review S-T01 data for VACS evidence
   - [ ] Draft provisional patent outline
   - [ ] Consult IP attorney (if available)

6. **📈 Analysis & Reporting Sprint**
   - [ ] Compute Phase 1 metrics across all experiments
   - [ ] Generate HTML/PDF reports for all runs
   - [ ] Write cross-experiment comparison

### Medium-Term (Next 3-4 Weeks)

7. **🔁 Iterative Validation**
   - [ ] Repeat high-SSR experiments for statistical power
   - [ ] Run ablation studies (with/without MEM, etc.)
   - [ ] Document failure modes and lessons

8. **✅ Phase 1 Gate Review**
   - [ ] Self-assessment against exit criteria
   - [ ] Decide: proceed to Phase 2 or extend Phase 1?
   - [ ] Update roadmap based on learnings

9. **🏗️ Phase 2 Planning**
   - [ ] Design Shadows v2/v3 implementations
   - [ ] Draft Phase 2 hardware campaign plan
   - [ ] Identify Phase 2 quick wins

---

## Part 9: Success Metrics & KPIs

### 9.1 Phase 1 Completion Metrics

**Primary (must achieve)**:
- [ ] S-T01/S-T02: ≥10 hardware runs, SSR ≥ 1.1 on IBM
- [ ] C/O/B/M: ≥1 run each with manifest + report
- [ ] Patent themes: Top 3 identified with supporting data
- [ ] Hardware validation: Complete with documented results

**Secondary (nice to have)**:
- [ ] Code coverage: 40%+ (up from 23%)
- [ ] CI coverage: 60%+ (vs target 80%)
- [ ] Cross-provider: At least 1 AWS Braket run

### 9.2 Weekly Progress Tracking

**Propose weekly check-ins**:
- **Mondays**: Plan week's experiments, check IBM runtime status
- **Wednesdays**: Mid-week progress review, adjust if needed
- **Fridays**: Data analysis, update checklist, plan next week

**Metrics to track**:
- Hardware runs completed (target: 2-3/week)
- Manifests generated (target: match hardware runs)
- Tasks checked off (target: 2-3/week)
- SSR measurements (target: ≥1.1 on all tests)

---

## Part 10: Conclusion & Recommendations

### 10.1 Overall Assessment

**Grade: B** (Good infrastructure, behind on experiments)

**Strengths**:
- ✅ Excellent strategic vision and roadmap
- ✅ Professional CI/CD and documentation
- ✅ Clear competitive differentiation
- ✅ Solid technical foundation

**Weaknesses**:
- ❌ Experimental execution significantly behind schedule
- ❌ Code coverage low for core algorithms
- ❌ Resource allocation skewed toward infrastructure

**Opportunity**:
- ⚡ **1 month sprint** can get Phase 1 back on track
- ⚡ Infrastructure is ready - just need to use it
- ⚡ Shifting 10% → 70% to experiments = 7× productivity increase

### 10.2 Critical Path Forward

**The next 31 days**:
1. **Focus obsessively on experiments** (70% of time)
2. Execute S-T01/S-T02 extended validation (20 runs)
3. Get first data drops from C/O/B/M (skeleton implementations)
4. Draft patent themes with experimental evidence
5. Prepare Phase 1 gate review

**Key principle**: **"Done is better than perfect"** for Phase 1. Get experimental data, even if implementations are basic.

### 10.3 Risk-Adjusted Recommendations

**Recommended Plan**:
1. **Accept 1-month Phase 1 extension** (Nov → Dec 2025)
   - More realistic given current progress
   - Maintains quality without excessive pressure

2. **Redefine Phase 1 exit criteria** (flexible gates)
   - Focus on experiments, accept technical debt
   - 40% code coverage instead of 80%
   - Provisional patent outline instead of filed provisional

3. **Merge Phase 1/2 objectives** (Nov-Dec 2025)
   - Run Phase 1 experiments + start Phase 2 planning in parallel
   - Begin patent drafting during experimental data collection

4. **Reassess in January 2026**
   - Formal Phase 2 start after holidays
   - Fresh roadmap based on Phase 1 learnings

### 10.4 One-Sentence Recommendation

**Stop polishing infrastructure, start running experiments daily, and produce 20+ hardware runs with manifests in the next month to validate the QuartumSE value proposition with real data.**

---

## Appendices

### Appendix A: Repository Health Metrics

```
Total Source Files: 26
Total Tests: 104
Total Documentation: 27 files
Commits (Oct 2025): 195
Code Coverage: 23%
CI Jobs: 9 (test×6 + integration×3)
Documentation Site: quartumse.com
```

### Appendix B: Experiment Status Matrix

| Experiment | Design | Implementation | Hardware Runs | Analysis | Report |
|------------|--------|----------------|---------------|----------|--------|
| S-T01 GHZ | ✅ | ✅ | ⚠️ (1/10) | ❌ | ❌ |
| S-T02 Noise | ✅ | ⚠️ | ❌ (0/10) | ❌ | ❌ |
| S-BELL | ✅ | ❌ | ❌ (0/10) | ❌ | ❌ |
| S-CLIFF | ✅ | ❌ | ❌ (0/10) | ❌ | ❌ |
| S-ISING | ✅ | ❌ | ❌ (0/10) | ❌ | ❌ |
| S-CHEM (H₂) | ✅ | ❌ | ❌ (0/6) | ❌ | ❌ |
| C-T01 VQE | ✅ | ❌ | ❌ (0/3) | ❌ | ❌ |
| O-T01 QAOA | ✅ | ❌ | ❌ (0/2) | ❌ | ❌ |
| B-T01 RB | ✅ | ❌ | ❌ (0/2) | ❌ | ❌ |
| M-T01 Phase | ✅ | ❌ | ❌ (0/1) | ❌ | ❌ |

**Summary**: 10 experiments planned, 1 partially complete (10%), 54 hardware runs needed.

### Appendix C: Lessons Learned Summary

From recent CI/CD debugging (docs/ops/lessons_learned_sphinx_ci.md):
1. Don't mix Sphinx and MkDocs documentation
2. Use suppress_warnings correctly (nitpick_ignore ≠ suppress_warnings)
3. Test documentation builds in CI
4. Document debugging processes for future reference
5. Follow your own lessons learned docs (PR #62 regression)

**Meta-lesson**: Technical debt (Sphinx regressions) can consume significant time. Prevention > firefighting.

---

**Document Status**: Draft for review
**Next Update**: After Phase 1 sprint (Nov 7, 2025)
**Feedback**: Please update this document as decisions are made and progress is tracked.
